Andersson, G.B., Epidemiological features of chronic low-back pain. Lancet, 1999; 345: 581-585.
Bekers, O., Uijtendaal, E.V., Beijnen, J.H., Bult, A., Underberg, W.J.M., Cyclodextrins in the pharmaceutical field. Drug Development and Industrial Pharmacy, 1991; 17: 1503-1549.
Bibby, D.C., Davies, N.M., Tucker, I.G., Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. International Journal of Pharmaceutics, 2000; 197: 1-11.
Bongers, P.M., de Winter, C.R., Kompier, M.A.J., Psychosocial factors at work and musculoskeletal disease. Scandinavian Journal of Work Environment and Health, 1993; 19: 297-312.
Borenstein, D.G., A clinician''s approach to acute low back pain. The American Journal of Medicine, 1997; 102: 16S-22S.
Carlson N.R., Reflexive control of movement. Foundations of physiological psychology. 3rd ed. Boston: Allyn & Bacon, 1995.
Conney, A.H., Burns, J.J., Physiological disposition and metabolic fate of chlorzoxazone (Paraflex) in man. Journal of Pharmacology and Experimental Therapeutics, 1960; 128: 340-343.
Croft, P.R., Macfarlane, G.J., Papageorgiou, A.C., Outcome of low back pain in general practice: a prospective study. British Medical Journal, 1998; 316: 1356-1359.
Cunningham, L.S., Kelsey, J.L., Epidemiology of musculoskeletal impairments and associated disability. American Journal of Public Health, 1984; 74: 574-579.
Desiraju, R.K., Renzi Jr., N.L., Nayak, R.K., Ng, K.T., Pharmacokinetics of chlorzoxazone in humans. Journal of Pharmaceutical Sciences, 1983; 72: 991-994.
Deyo, R.A., Tsui-Wu, Y.J., Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine, 1987; 12: 264-268.
Dienst, E.S. van, Water-soluble cyclodextrin-based host molecules. Ph.D. thesis. Netherlands: University of Twente, 1994.
Elenbaas, J.K., Central acting oral skeletal muscle relaxants. American Journal of Hospital Pharmacy, 1980; 37: 1313-1323.
European Directorate for the Quality of Medicines, European Pharmacopoeia. 4th ed. Supplement 4.1. Strasbourg, 2002: 2435.
Frymoyer, J.W., Back pain and sciatica. New England of Journal of Medicine, 1988; 318: 291-300.
Frömming, K.H., Szejtli, J., Cyclodextrins in Pharmacy. 1st ed. Dordrecht, 1994.
Gennaro, A.R., Centrally acting muscle relaxants. Textbook of Remington: The science and practice of pharmacy 20th ed. Williams & Wilkins, 2000: 1337-1338.
Higuchi, T., Connors, K. A., Phase-solubility techniques. Advances in Analytical Chemistry and Instrumentation, 1965: 117-212.
Kasper, D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L., Jameson, J.L., Harrison’ s principles of internal medicine 16th ed. New York: McGraw-Hill, 2004.
Kerč, J., Srčič, S., Urleb, U., Kanalec, A., Kofler, B., Šmid-Korbar, J., Compatibility study between acetylcysteine and some commonly used tablet excipients. The Journal of Pharmacy and Pharmacology, 1992; 44: 515-518.
Lamberts, H., In Het Huis Van de Huisarts. Verslag van het Transitieprojekt. Lelystad: Meditekst, 1991.
Leboeuf-Yde, C., Smoking and low back pain: a systematic literature review of 41 journal articles reporting 47 epidemiologic studies. Spine, 1999; 24: 1463-1470.
Leboeuf-Yde, C., Body weight and low back pain: a systematic literature review of 56 journal articles reporting on 65 epidemiologic studies. Spine, 2000a; 25: 226-237.
Leboeuf-Yde, C., Alcohol and low back pain: a systematic literature review. Journal of Manipulative and Physiological Therapeutics, 2000b; 23: 343-346.
Linton, S.J., Occupational psychological factors increase the risk for back pain: a systematic review. Journal of Occupational Rehabilitation, 2001; 11: 53-66.
Loftsson, T., Brewster, M.E., Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. Journal of Pharmaceutical Sciences, 1996; 85: 1017-1025.
Loftsson, T., Johannesson, H.R., The influence of cyclodextrin on the stability of cephalotin and aztreonam in aqueous solutions. Pharmazie, 1994; 49: 292-293.
Malanga, G.A., Nadler, S.F., Lipetz, J., Pharmacologic treatment of low back pain. In Physical Medicine and Rehabilitation State of the Art Reviews, Philadelphia: Hanley and Belfus, 1999; 13: October.
Mens, J.M., The use of medication in low back pain. Best Practice & Research Clinical Rheumatology, 2005; 19: 609-621.
Montgomery, D.C., Design and analysis of experiments. 4th ed. New York: John Wiley & Sons, 1996 : 301-315.
Moyano, J.R., Arias-Blanco, M.J., Gines, J.M., Giordano, F., Solid-state characterization and dissolution characteristics of gliclazide-β- cyclodextrin inclusion complexs. International Journal of Pharmaceutics, 1997; 148: 211-217.
Nachemson, A. L., Advances in low back pain. Clinical Orthopaedics and Related Research, 1985; 200: 266-218.
Rawat, S., Jain, S.K., Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes. European Journal of Pharmaceutics and Biopharmaceutics, 2004; 57: 263-267.
Reeves, R.R., Algood, T.L., Wise, P.M., Skeletal muscle relaxants and associated medications for nonspecific acute back pain. Pharmacy and Therapeutics, 2005; 30: 518-524.
Seager, H., Drug-delivery products and the Zydis fast-dissolving dosage form. Journal of Pharmacy and Pharmacology, 1998; 50: 375-382.
Saenger, W., Angewandte Chemie. International edition in English., 1980; 19: 344.
Skiba, M., Mor van, C., Duchene, D., Puisieux, F., Wouessidjewe, D., Evaluation of gastrointestinal behaviour in the rat of amphiphilic β-cyclodextrin nanocapsules, loaded with indomethacin. International Journal of Pharmaceutics, 1995; 126: 275-279.
Sridar, V.C., Timothy, S.T., Rapid and sensitive high-performance liquid chromatographic assay for 6-hydroxychlorzoxazone and chlorzoxazone in liver microsomes. Journal of Chromatography B: Biomedical Sciences and Applications, 1997; 693: 479-483.
Sunada, H. and Bi, Y., Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technology, 2002; 122: 188-198.
Szejtli, J., Gerloczy, A., Sebestyen, G., Fonagy, A., Influencing of resorption and side-effects of salicylic acid by complexing with beta-cyclodextrin. Pharmazie, 1981; 36: 283-286.
Szejtli, J., Introduction and general overview of cyclodextrin chemistry. Chemical Reviews, 1998; 98: 1743-1754.
Szejtli, J., Szente, L., Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. European Journal of Pharmaceutics and Biopharmaceutics, 2005; 61: 115-125.
Tommasini, S., Raneri, D., Ficarra, R., Calabro, M.L., Stancanelli, R. and Ficarra, P., Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin. Journal of Pharmaceutical and Biomedical Analysis, 2004; 35: 379-387.
Tulder, M. van, Koes, B., Bombardier, C., Low back pain. Best Practice & Research Clinical Rheumatology, 2002; 15: 761-775.
Uekama, K., Hirashima, N., Horiuchi, H., Hirayama, F., Ijitsu, T., Ueno, M., Ethylated β-cyclodextrins as hydrophobic drug carriers: sustained release of diltiazem in the rat. Journal of Pharmaceutical Sciences, 1987; 76: 660-661.
Umemura, M., Ueda, H., Tomono, K., Nagai, T., Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations. Drug Design and Delivery, 1990; 6: 297-310.
Villiers, A., Cyclodextrins and their use. Compt Rendu, 1891; 112: 536-540.
Waldman, H.J., Centrally acting skeletal muscle relaxants and associated drugs. Journal of Pain and Symptom Management, 1994; 9: 434-441.
林頌凱,張煥禎,下背痛的診斷與治療。基層醫學,2004;19:282-287。沈明來,試驗設計學。台北:九州圖書文物有限公司,2004。
郭浩然,職業性下背痛。中華公共衛生雜誌,2000;19:332-339。鄭碧華,吳聰能。下背痛病因學和危險因子上的新焦點。台灣公共衛生雜誌,2001;20:172-174。